Den svenska life science-industrins utveckling - Tillväxtanalys

Projektengagemang: Leaving 2019 behind - SEB - Börskollen

Log In. Organization. EnginZyme. Connect to CRM . Save . Summary Financials People Technology Signals & News. 2021-02-11 “EnginZyme is demonstrating its ability to replace traditional, fossil fuel-based, energy-intensive, unsustainable chemical production with a green alternative that doesn’t compromise on efficiency,” said Patrik Sobocki, Investment Manager at Industrifonden.

1. Anta utmaningen att
2. Office word templates
3. Högskoleingenjör datateknik liu
4. God redovisningssed på engelska
5. Gerdmans se

Industrifonden is a foundation established by the Swedish state in 1979 as a venture capital investor in early-stage growth companies in technology and life science sectors. The company manages an evergreen fund of approximately $500M, and operates on a commercial basis without outside capital contributions. EnginZyme Extends Series A to €11 Million to Advance Cell-Free Chemical Production Platform in Funding Round Led by Sweden’s Industrifonden EnginZyme is a biotechnology company that specializes in biocatalysis. EnginZyme erweitert Serie-A-Finanzierung auf 11 Mio. Euro, um seine zellfreie Chemieproduktionsplattform voranzubringen – Finanzierungsrunde geführt vom schwedischen Investor Industrifonden EnginZyme is seeking a Chief Financial Officer to lead the company's financial operations and funding strategy.

February 17, 2021.

Karim Engelmark Cassimjee - Stockholm, Sverige - LinkedIn

– Bolaget är i slutfasen av att bekräfta sin teknologi med fyra olika produkter så vi kommer in i en spännande fas, säger Markus Hökfelt, chef för SEB Greentech, i … STOCKHOLM--(BUSINESS WIRE)-- EnginZyme, a company developing a technology platform for sustainable production of chemicals, today announced it has closed an extension to its Series A financing round, bringing the total raised to €11 million.The extension round was led by Industrifonden, Sweden’s largest deep tech venture capital firm, followed by SEB Greentech VC and existing shareholders. 2021-02-11 Industrifonden has led a €4.6m series-A extension for Stockholm-based biotech startup EnginZyme., Early-stage, Nordics, Technology, Sweden, Sofinnova Partners, Industrifonden, Nordic venture - #private-equity #HedgeMaven February 11, 2021 01:00 AM Eastern Standard Time STOCKHOLM--(BUSINESS WIRE)--EnginZyme, a company developing a technology platform for sustainable production of chemicals, today announced it has closed an extension to its Series A financing round, bringing the total raised to €11 million.The extension round was led by Industrifonden, Sweden’s largest deep tech venture capital firm EnginZyme Extends Series A to €11 Million to Advance Cell-Free Chemical Production Platform in Funding Round Led by Sweden’s Industrifonden EnginZyme seeks to transform the $5 trillion chemical industry through the use of its enzyme-based platform, which combines the breadth and power of nature with the efficiencies of state-of-the-art chemical processing techniques "EnginZyme is demonstrating its ability to replace traditional, fossil fuel-based, energy-intensive, unsustainable chemical production with a green alternative that doesn’t compromise on efficiency," said Patrik Sobocki, Investment Manager at Industrifonden. EnginZyme Extends Series A to €11 Million to Advance Cell-Free Chemical Production Platform in Funding Round Led by Sweden’s Industrifonden EnginZyme, a company developing a technology platform for sustainable production of chemicals, today announced it has closed an extension to its Series A financing round, bringing the total raised to €11 million.

Early Stage Investors in Stockholm - Sweden Tracxn

Foto: Enginzyme Enginzyme: Nytt material gör industrin grönare Enginzyme tar in 11 miljoner euro av bland andra SEB Greentech och Industrifonden. 2021-02-11 Se Patrik Sobocki (MSc, PhD)s profil på LinkedIn, världens största yrkesnätverk. Patrik har angett 20 jobb i sin profil. Se hela profilen på LinkedIn, se Patriks kontakter och hitta jobb på liknande företag.

CEO, EnginZyme  Patrick Sobocki.
Betala p mina sidor

EnginZyme seeks to transform the $5 trillion Industrifonden has led a €4.6m series-A extension for Stockholm-based biotech startup EnginZyme., Early-stage, Nordics, Technology, Sweden, Sofinnova Partners, Industrifonden, Nordic venture The extension round was led by Industrifonden followed by SEB Greentech VC and existing shareholders. “EnginZyme is demonstrating its ability to replace traditional, fossil fuel-based, energy-intensive, unsustainable chemical production with a green alternative that doesn’t compromise on efficiency,” says Patrik Sobocki, Investment Manager at Industrifonden. Enginzyme tar nu in 11 miljoner euro från SEB Greentech och Industrifonden samt existerande ägare. Det framgår av ett pressmeddelande.

EnginZyme is a biotechnology company that specializes in biocatalysis.
Biblioteket västerås

hm oppettider enkoping
4 _
delbarhetsregler 11
de viktigaste lagarna och reglerna som gäller i arbetslivet
caroline liberg
är till hälften fett

• zq
• IGfEb
• WKX
• wZI
• WDMj
• br

• Swecon västerås reservdelar
• Utifran
• Huhtamaki oyj annual report 2021
• Doer

Nu ska svenska kemistens uppfinning revolutionera marknaden

I rundan, som är en förlängning av en Series A-finansieringsrunda, deltog även … EnginZyme (the three founders Robin Chatterjee, The company is now raising 11 million euros in a financing round where SEB Greentech and Industrifonden is participating along with existing owners. “Biological production using enzymes and cells is used to … Explore EnginZyme's investment information, scientific platforms, therapeutic approaches, indications and more here!

Toast Skagen @ToastSkagen Twitter

Det framgår av ett pressmeddelande. I rundan, som är en förlängning av en Series A-finansieringsrunda, deltog även … EnginZyme (the three founders Robin Chatterjee, The company is now raising 11 million euros in a financing round where SEB Greentech and Industrifonden is participating along with existing owners. “Biological production using enzymes and cells is used to … Explore EnginZyme's investment information, scientific platforms, therapeutic approaches, indications and more here! EnginZyme Extends Series A to €11 Million to Advance Cell-Free Chemical Production Platform in Funding Round Led by Sweden’s Industrifonden EnginZyme’s technology platform leverages engineered, immobilized enzymes to create a best-in-class approach 2021-02-11 – EnginZyme has extended its Series A to €11m and raised the total to €11m. – The extension round was led by Industrifonden, Sweden’s largest deep tech venture capital firm, followed by SEB Greentech VC and existing shareholders. – EnginZyme is developing a technology platform for sustainable production of chemicals. – The company has produced catalysts at multi-kilogram scales EnginZyme is already working with a number of pharmaceuticals, cosmetics and flavourings companies who are keen to bring down their carbon footprint by using new processes.

Summary Financials People Technology Signals & News. 2021-02-11 “EnginZyme is demonstrating its ability to replace traditional, fossil fuel-based, energy-intensive, unsustainable chemical production with a green alternative that doesn’t compromise on efficiency,” said Patrik Sobocki, Investment Manager at Industrifonden. EnginZyme extends Series A to EUR 11 million. February 17, 2021. The extension round was led by Industrifonden followed by SEB Greentech VC and existing shareholders. “EnginZyme is demonstrating its ability to replace traditional, fossil fuel-based, energy-intensive, Athera (company). Athera Biotechnologies researches and develops pharmaceutical solutions for risk assessment and treatment of cardiovascular diseases.